A RANDOMISED CONTROL STUDY TO COMPARE THE EFFICACY OF CEFUROXIME, CLARITHROMYCIN, AND LEVOFLOXACIN IN THE MANAGEMENT OF PAEDIATRIC UPPER RESPIRATORY TRACT INFECTION
Keywords:Upper respiratory tract infections, Clarithromycin, Cefuroxime, Levofloxacin, Pediatrics
Background: The upper respiratory infections cause considerable morbidity mainly in children due to the fact that they mainly affect children. Accordingly, a study was conducted on antibiotics to compare the effectiveness of clarithromycin, cefuroxime, and levofloxacin for treating upper respiratory tract infections (URTI) in children.
Methods: A prospective observational study for a period of 6 months was conducted in the pediatrics department of RVM hospital. Outpatients under the age of 14 years given antibiotics for the treatment of URTI were included in the study. A total of 99 study subjects were included in the study, divided into three groups each containing 33 sample sizes (clarithromycin, cefuroxime, and levofloxacin). Patient data was collected using a form and verbal consent was obtained from patients/patient representatives, and drugs were given using the lottery method. Follow-up was done and noted for the 3rd, 5th, 7th day through telephonic calls, and the collected data were evaluated using statistical analysis.
Results: Pool data from 99 patients shows that many patients belong to 0–5 years age groups (age distribution), and males were more than female (gender distribution). Clarithromycin (cure rate 3 days) and cefuroxime (cure rate 5 days) showed an equal rate of cure percentage (94%), while levofloxacin for 3–5 days with a 3% failure rate. A significant difference of p<0.05 (p=0.000) was observed and no adverse events were noted.
Conclusion: The study findings showed, out of 3 drugs, clarithromycin and cefuroxime showed an equal efficacy rate of 94%, but clarithromycin showed shorter duration of outcome, i.e., 3 days. Hence, clarithromycin is effective than the other two drugs in the treatment of URTI.
Health A-Z; 2021. Available from: https://www.hse.ie/eng/health/ az/r/respiratory-tract-infection/causes-of-RTI-infections.html. [Last accessed on 2021 Aug 20].
Middle East Journal of Family Medicine; 2018. Available from: http:// www.mejfm.com/journal/May2006/epidemiology.htm. [Last accessed on 2021 Aug 20].
Influenza. World Health Organization; 2019. Available from: https:// www.who.int/immunization/diseases/influenza/en. [Last accessed on 2021 Aug 20].
Emedicinehealthline: Medical Author; 2017. Available from: https:// www.emedicinehealth.com/epiglottitis/article_em.htm. [Last accessed on 2021 Aug 20].
Chadalavada V, Triveni P, Begum S, Pujitha S. Drug use evaluation in the pediatrics admitted with severe respiratory tract infections. J Global Pharma Technol 2020;12:13-21.
Harria G. Superbugs’ Kill India’s Babies and Pose an Overseas Threat, The New York Times; 2014. Available from: https://www.nytimes.com/2014/12/04/world/asia. [Last accessed on 2021 Aug 20].
Rajesh B, Walia K. Combating antimicrobial resistance in India: Technical challenges and opportunities. Indian J Med Res 2017;146:683- 7.
Indian Council of Medical Research. Treatment Guidelines for Antimicrobial Use in Common Syndromes; 2017. Available from: https://www.icmr.nic.in/guidelines. [Last accessed on 2021 Aug 20].
World Health Organization. Model List of Essential Medicines; 2019. Available from: https://www.apps.who.int. [Last accessed on 2021 Aug 20].
World Health Organization. Collaborating Center for Drug Statistics Methodology; 2019. Available from: https://www.whocc.no/atc_ddd_ index. [Last accessed on 2021 Aug 20].
Guay D, Siepman N, Tanaka S, Devcich K, Craft J. Comparative safety and efficacy of clarithromycin and 3 oral cephalosporins in the treatment of outpatients with bacterial bronchitis due to Haemophilus influenzae. Drug Investig 2012;6:33-41.
Henry DC. Comparison of cefuroxime axetil and amoxicillin/ clavulanate in the treatment of acute bacterial sinusitis. Clin Ther1999;21:1158-70.
Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Katie Rielly- Gauvin BS, et al. Multicenter, Investigator-Blinded, Randomized Comparison of Oral Levofloxacin and Oral Clarithromycin. 1998;1255- 1263.
Noel GJ. A Randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent Acute OM. Pediatr Infect Dis J 2008;27:483-9.
Weiss LR. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbation of chronic bronchitis. Clin Ther 2002;24:1414-25.
World Health Organization Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation; 2020. Available from: https://www.who.int/medicines/areas/rational_use/amu_surveillance/ en. [Last assessed on 2019 Jun 06].
Balamurugan K. Vineela CH, Manoharbabu S. A review on role of pharmacists: Antimicrobial stewardship and in the battle against antimicrobial resistance in India. J Pharm Sci Innov 2018;7:91-7.
How to Cite
Copyright (c) 2021 GOUTHAMI PADUGUNDLA, JYOTHIRMAYEE V, BETHALA RAVALI, JAGILLAPURAM ARUNDHATHI, THAKUR SRILATHA, NOORBASHA NISSI, ARSHIYA ANJUM
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.